Sang Ming, Liu Jin-Biao, Dai Ming, Wu Jian-Guo, Ho Wen-Zhe
ABSL-III Laboratory at the Center for Animal Experiment, Wuhan University School of Basic Medical Sciences, Wuhan, People's Republic of China; State Key Laboratory of Virology, Wuhan University, Wuhan, People's Republic of China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, College of Basic Medical Sciences, Hubei University of Medicine, Shiyan, People's Republic of China.
ABSL-III Laboratory at the Center for Animal Experiment, Wuhan University School of Basic Medical Sciences, Wuhan, People's Republic of China; State Key Laboratory of Virology, Wuhan University, Wuhan, People's Republic of China.
Antiviral Res. 2014 Dec;112:103-12. doi: 10.1016/j.antiviral.2014.10.008. Epub 2014 Oct 23.
Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate antiviral immunity against viral infections. Here we demonstrate that TLR3 signaling of monocyte-derived macrophages (MDM) from rhesus monkeys by poly I:C inhibited simian immunodeficiency virus (SIV) infection and replication. Investigation of the mechanisms showed that TLR3 activation resulted in the induction of type I and type III interferons (IFNs) and IFN-inducible antiviral factors, including APOBEC3G (A3G), tetherin and SAMHD1. In addition, poly I:C-treated macaque macrophages expressed increased levels of CC chemokines including CCL3, CCL4 and CCL5, the ligands for HIV or SIV coreceptor CCR5. Furthermore, TLR3 signaling of macaque macrophages induced the expression of cellular microRNAs (miR-29a, -29b, -146a and -9), the newly identified intracellular SIV restriction factors. TLR3 activation-mediated anti-SIV effect could be compromised by the knockdown of IRF3 and IRF7. These findings indicate that TLR3-mediated induction of multiple viral restriction factors contribute to the inhibition of SIV infection in macaque macrophages, which support future preclinical studies using rhesus macaques to determine whether in vivo TLR3 activation is safe and beneficial for treating people infected with HIV.
Toll样受体3(TLR3)可识别双链RNA,并引发多种细胞内事件,这些事件负责针对病毒感染的先天性抗病毒免疫。在此,我们证明,通过聚肌胞苷酸(poly I:C)对恒河猴单核细胞衍生的巨噬细胞(MDM)进行TLR3信号传导,可抑制猿猴免疫缺陷病毒(SIV)的感染和复制。对其机制的研究表明,TLR3激活导致I型和III型干扰素(IFN)以及IFN诱导的抗病毒因子的诱导,包括载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G,A3G)、束缚素和SAM域和HD结构域包含蛋白1(SAMHD1)。此外,经poly I:C处理的猕猴巨噬细胞表达的CC趋化因子水平升高,包括CC趋化因子配体3(CCL3)、CC趋化因子配体4(CCL4)和CC趋化因子配体5(CCL5),它们是HIV或SIV共受体CC趋化因子受体5(CCR5)的配体。此外,猕猴巨噬细胞的TLR3信号传导诱导了细胞微小RNA(miR-29a、-29b、-146a和-9)的表达,这些是新发现的细胞内SIV限制因子。IRF3和IRF7的敲低可能会削弱TLR3激活介导的抗SIV效应。这些发现表明,TLR3介导的多种病毒限制因子的诱导有助于抑制猕猴巨噬细胞中的SIV感染,这为未来使用恒河猴进行临床前研究以确定体内TLR3激活对治疗HIV感染者是否安全和有益提供了支持。